Treatment of DIC with a Primary Hyperfibrinolytic State and Severe Bleeding
Disseminated intravascular coagulation (DIC) presents heterogeneously. When the dominant pathophysiology is a primary hyperfibrinolytic state and the patient presents with severe bleeding, this sub-population requires a specifically targeted management approach.
Clinical scenario: DIC characterized by a primary hyperfibrinolytic state, presenting with severe bleeding. Identifying this pattern is essential before selecting the appropriate intervention.
Treatment direction: The evidence-based approach in this scenario involves the use of
lysine analogues — a class of antifibrinolytic agents — to address the hyperfibrinolytic component driving the bleeding.
Full regimen details, dosing guidance, and the complete algorithm are available in the structured protocol below.
References
Patients with DIC that is characterized by a primary hyperfibrinolytic state and who present with severe bleeding could be treated with lysine analogues, such as tranexamic acid (e.g. 1 g every 8 h) (Grade C, Level IV).
DOI: 10.1111/j.1365-2141.2009.07600.x
View source ↗